ZYLOXTB buys back 56,500 H shares; treasury stock now at 10.77 million

Bulletin Express

Jun 03

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 56,500 H shares on 03 June 2026, executed on the Hong Kong Stock Exchange at prices ranging from HKD 19.16 to HKD 20.20. The transaction amounted to HKD 1.11 million, implying a volume-weighted average price of HKD 19.68 per share.

Following the buyback, issued shares excluding treasury stock decreased by 0.0169% to 325.58 million, while treasury shares increased to 10.77 million. Total issued shares remained unchanged at 336.35 million.

Under the general mandate approved on 13 May 2026, the company is authorised to repurchase up to 32.72 million shares. Cumulative buybacks since the mandate’s approval now stand at 1.62 million shares, representing 0.485% of the issued share base as of the mandate date.

A 30-day moratorium on new share issues, sales, or transfers of treasury shares is in effect until 03 July 2026, in accordance with Main Board Rule 10.06(3)(a).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1121995540"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121995540\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121995540?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 19:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121995540","market":"us","top_or_hot":-1,"title":"ZYLOXTB buys back 56,500 H shares; treasury stock now at 10.77 million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 56,500 H shares on 03 June 2026, executed on the Hong Kong Stock Exchange at prices ranging from HKD 19.16 to HKD 20.20. The transaction amounted to HKD 1.11 million, implying a volume-weighted average price of HKD 19.68 per share.</p>\n<p>Following the buyback, issued shares excluding treasury stock decreased by 0.0169% to 325.58 million, while treasury shares increased to 10.77 million. Total issued shares remained unchanged at 336.35 million.</p>\n<p>Under the general mandate approved on 13 May 2026, the company is authorised to repurchase up to 32.72 million shares. Cumulative buybacks since the mandate’s approval now stand at 1.62 million shares, representing 0.485% of the issued share base as of the mandate date.</p>\n<p>A 30-day moratorium on new share issues, sales, or transfers of treasury shares is in effect until 03 July 2026, in accordance with Main Board Rule 10.06(3)(a).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZYLOXTB buys back 56,500 H shares; treasury stock now at 10.77 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZYLOXTB buys back 56,500 H shares; treasury stock now at 10.77 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 19:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 56,500 H shares on 03 June 2026, executed on the Hong Kong Stock Exchange at prices ranging from HKD 19.16 to HKD 20.20. The transaction amounted to HKD 1.11 million, implying a volume-weighted average price of HKD 19.68 per share.</p>\n<p>Following the buyback, issued shares excluding treasury stock decreased by 0.0169% to 325.58 million, while treasury shares increased to 10.77 million. Total issued shares remained unchanged at 336.35 million.</p>\n<p>Under the general mandate approved on 13 May 2026, the company is authorised to repurchase up to 32.72 million shares. Cumulative buybacks since the mandate’s approval now stand at 1.62 million shares, representing 0.485% of the issued share base as of the mandate date.</p>\n<p>A 30-day moratorium on new share issues, sales, or transfers of treasury shares is in effect until 03 July 2026, in accordance with Main Board Rule 10.06(3)(a).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1121995540","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121995540","pubTimestamp":1780485786,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 56,500 H shares on 03 June 2026, executed on the Hong Kong Stock Exchange at prices ranging from HKD 19.16 to HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"ZYLOXTB回购56,500股H股；库存股目前为1077万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a repurchase of 56,500 H shares on 03 June 2026, executed on the Hong Kong Stock Exchange at prices ranging from HKD 19.16 to HKD 20.20. The transaction amounted to HKD 1.11 million, implying a volume-weighted average price of HKD 19.68 per share.\nFollowing the buyback, issued shares excluding treasury stock decreased by 0.0169% to 325.58 million, while treasury shares increased to 10.77 million. Total issued shares remained unchanged at 336.35 million.\nUnder the general mandate approved on 13 May 2026, the company is authorised to repurchase up to 32.72 million shares. Cumulative buybacks since the mandate’s approval now stand at 1.62 million shares, representing 0.485% of the issued share base as of the mandate date.\nA 30-day moratorium on new share issues, sales, or transfers of treasury shares is in effect until 03 July 2026, in accordance with Main Board Rule 10.06(3)(a).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}